Skip to main content
. 2020 Aug 31;9(9):2821. doi: 10.3390/jcm9092821

Figure 4.

Figure 4

Schematic representation of the Toll-Like Receptor 2 (TLR2)/IL-15/NF-κB pathway in pSS SGEC. TLR2, in response to pro-inflammatory stimuli, activate the NF-κB pathway; in the nucleus, the active NF-κB promote IL-15 gene transcription; thus, incrementing inflammatory disorders in SGs of pSS patients.